Association between non‐alcoholic fatty liver disease and risk of new‐onset atrial fibrillation in healthy adults

Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis

(2019) Alessandro Mantovani et al.   LIVER INTERNATIONAL

Obesity Paradox and Smoking Gun

(2018) Xi-Yong Yu et al.   CIRCULATION RESEARCH

PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study

(2018) Melissa E Middeldorp et al.   EUROPACE

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

(2018) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

(2017) Sean S. Lee et al.   EUROPEAN HEART JOURNAL

Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population

(2016) Marcello Ricardo Paulista Markus et al.   ATHEROSCLEROSIS

Epidemiology and natural history of non-alcoholic fatty liver disease

(2016) Yousef Fazel et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease

(2015) Salvatore Petta et al.   JOURNAL OF HEPATOLOGY

External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan

(2015) Bi-Ling Yang et al.   PLoS One

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)

(2015) Aki J. Käräjämäki et al.   PLoS One

Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort

(2014) Alvaro Alonso et al.   HEART

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes

(2013) Giovanni Targher et al.   PLoS One

Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability

(2013) Yu-Chen Liu et al.   PLoS One

Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation

(2012) Moritz F. Sinner et al.   AMERICAN JOURNAL OF CARDIOLOGY

Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation

(2011) Chiadi E. Ndumele et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features

(2011) Gianluca Iacobellis et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey

(2009) Duk-Hee Lee et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION